NASDAQ
04.03.25 | 22:00
0,095 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | Zomedica Corp.: Zomedica Expands Distribution of TRUVIEW Digital Microscopy Platform Through National Agreement with Moichor, a Leader in Veterinary Pathology | 1.289 | ACCESS Newswire | Partnership Expected to Accelerate System Placements and Support Recurring Consumables Revenue Growth ANN ARBOR, MI / ACCESS Newswire / February 25, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or... ► Artikel lesen | |
| 05.02. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on February 27th Focused on Research & Development and Its Innovation Pipeline | 491 | ACCESS Newswire | February session to highlight how Zomedica's R&D strategy supports scalable growth and long-term shareholder value ANN ARBOR, MI / ACCESS Newswire / February 5, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 23.01. | Zomedica Corp.: Zomedica Expands its TRUVIEW Microscopy Platform with AI Diagnostic Interpretation, Growing its Market Opportunity | 1.007 | ACCESS Newswire | AI-enabled hematology and cytology analysis improves diagnostic speed, consistency, and workflow efficiency for veterinary clinics ANN ARBOR, MI / ACCESS Newswire / January 23, 2026 / Zomedica Corp.... ► Artikel lesen | |
| 22.01. | Zomedica Corp.: Zomedica Enters Contract Manufacturing and Services Agreement with Rahm Sensor Development to Expand Revenue Streams Beyond Animal Health | 391 | ACCESS Newswire | Agreement leverages existing infrastructure to add contract-based revenue, improve asset utilization, support long-term cash flow and create shareholder value through diversified markets ANN ARBOR,... ► Artikel lesen | |
| 14.01. | Zomedica Corp.: Zomedica Announces "Fourth Friday at Four" Webinar on January 23rd Focused on Digital Innovation & Technology-Driven Growth | 582 | ACCESS Newswire | January session to highlight Zomedica's expanding digital capabilities and long-term innovation strategy ANN ARBOR, MI / ACCESS Newswire / January 14, 2026 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 30.12.25 | Zomedica Corp.: Zomedica Launches Next-Generation VETGuardian PLUS Monitor, Expanding Core Monitoring Platform in Growing Veterinary Market | 340 | ACCESS Newswire | New platform improves workflow efficiency, strengthens clinical confidence, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / December 30, 2025 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| ZOMEDICA Aktie jetzt für 0€ handeln | |||||
| 11.12.25 | Zomedica Corp.: Zomedica Announces Collaboration with Prime Video as Assisi Loop Products Appear in New Holiday Film Merv | 449 | ACCESS Newswire | The collaboration highlights Zomedica's commitment to expanding pet wellness education as Assisi Loop technology is featured in the highly anticipated movie Merv now available on Prime Video ANN ARBOR... ► Artikel lesen | |
| 04.12.25 | Zomedica Corp.: Zomedica Expands TRUFORMA Diagnostic Menu with Launch of Equine Progesterone Assay | 373 | ACCESS Newswire | Newest assay expands TRUFORMA market opportunity by building on endocrinology foundation to address reproductive health in the equine segment ANN ARBOR, MI / ACCESS Newswire / December 4, 2025 / Zomedica... ► Artikel lesen | |
| 24.11.25 | Zomedica steigert Umsatz um 16 %, verfehlt aber Gewinnprognose - Aktie legt dennoch kräftig zu | 8 | Investing.com Deutsch | ||
| 11.11.25 | Zomedica Corp.: Zomedica Announces "Friday at Four" Webinar on November 21st Providing Strategic Overview & Third Quarter 2025 Business Review | 453 | ACCESS Newswire | November session to provide strategic context for Zomedica's product platforms featured in the previous Fourth Friday at Four Webinars ANN ARBOR, MI / ACCESS Newswire / November 11, 2025 / Zomedica... ► Artikel lesen | |
| 06.11.25 | Zomedica Corp.: Zomedica Achieves ISO 13485 Certification, Underscoring Strengthened Quality Infrastructure and Commercial Potential | 426 | ACCESS Newswire | Certification enhances global market readiness, reinforces quality systems, and supports Zomedica's long-term growth strategy ANN ARBOR, MI / ACCESS Newswire / November 6, 2025 / Zomedica Corp. (OTCQB:ZOMDF)... ► Artikel lesen | |
| 04.11.25 | Zomedica reports Q3 results | 4 | Seeking Alpha | ||
| 04.11.25 | Zomedica Corp.: Zomedica Announces Third Quarter 2025 Financial Results: Revenue up 16% to $8.1 Million with 67% Gross Margins and $54 Million in Liquidity to Support Growth | 551 | ACCESS Newswire | Zomedica posts highest quarterly revenue ever and record year-over-year revenue for 19th straight quarter! ANN ARBOR, MI / ACCESS Newswire / November 4, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica"... ► Artikel lesen | |
| 04.11.25 | Zomedica Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.11.25 | Zomedica Corp. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 23.10.25 | Zomedica Corp.: Zomedica Announces Launch of the Assisi Loop Lounge, Scientifically Backed tPEMF Therapy for Pets | 828 | ACCESS Newswire | Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's leadership in targeted... ► Artikel lesen | |
| 14.10.25 | Zomedica Corp.: Zomedica Expands Grovet's Distribution Agreement to Include Zomedica's Diagnostic and Therapeutic Device Products Across the European Union | 424 | ACCESS Newswire | Expanded agreement strengthens Zomedica's European presence, broadens product portfolio on the market, and positions the Company to capture growth in the multi-billion-dollar global veterinary diagnostics... ► Artikel lesen | |
| 09.10.25 | Zomedica Corp.: Zomedica to Spotlight VETGuardian Zero Touch Monitor in October "Fourth Friday at Four" Webinar | 327 | ACCESS Newswire | Live session on October 24th will showcase how the VETGuardian Monitor enhances patient care, improves workflow efficiency, and expands global market opportunities ANN ARBOR, MI / ACCESS Newswire /... ► Artikel lesen | |
| 23.09.25 | Zomedica Corp.: Zomedica Expands TRUFORMA Diagnostic Platform with Addition of Feline Use to Cobalamin & Folate Assay | 469 | ACCESS Newswire | First and only in-clinic multiplexed Cobalamin & Folate assay now validated for feline patients ANN ARBOR, MI / ACCESS Newswire / September 23, 2025 / Zomedica Corp. (OTCQB:ZOMDF) ("Zomedica" or the... ► Artikel lesen | |
| 18.09.25 | Zomedica Corp.: Zomedica Expands TRUVIEW and TRUFORMA Intellectual Property Portfolio with Four Newly Issued U.S. Patents | 320 | ACCESS Newswire | Intellectual property portfolio now includes 228 Patents and 153 Trademarks providing robust protection for the Company's product platforms in the rapidly growing multi-billion dollar veterinary diagnostics... ► Artikel lesen |
1 2 Weiter >>
38 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 41,370 | -1,83 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,78 | -0,24 % | Aktien Frankfurt Ausblick: Dax-Stabilisierung über 25.000 Punkten erwartet | FRANKFURT (dpa-AFX) - Nach einem schwachen Wochenauftakt für den Dax können die Anleger am Dienstag auf eine Stabilisierung hoffen. Eine Stunde vor Handelsbeginn signalisierte der X-Dax als außerbörslicher... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,840 | +0,99 % | Einführung des neuen Dialysegeräts bremst Fresenius Medical Care in 2026 | BAD HOMBURG (dpa-AFX) - Nach einem Gewinnsprung 2025 dürfte sich die Dynamik beim Dialyseanbieter Fresenius Medical Care (FMC) Medicaldeutlich verlangsamen. Konzernchefin Helen Giza schließt für das... ► Artikel lesen | |
| GENEDX | 74,20 | -6,98 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| PROGYNY | 17,600 | 0,00 % | KeyBanc senkt Kursziel für Progyny-Aktie aufgrund konservativer Schätzungen | ||
| PROCEPT BIOROBOTICS | 25,920 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,570 | +0,46 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 25,800 | -4,87 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| GERRESHEIMER | 16,120 | -4,90 % | ANALYSE-FLASH: UBS senkt Gerresheimer auf 'Sell' - Ziel mehr als halbiert | ZÜRICH (dpa-AFX) - Die Schweizer Großbank UBS hat das Kursziel für Gerresheimer von 29,00 auf 12,90 Euro eingestampft und die Aktien von "Neutral" auf "Sell" abgestuft. Olivier Calvet analysierte am... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 19,640 | +2,19 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| HEARTFLOW | 24,050 | +4,00 % | Heartflow, Inc.: Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease | Lesion-specific FFRCT predicts individual cardiovascular outcomes and delivers greater-than-modeled cost savings for real-world population in FISH&CHIPS analyses from England's National Health ServiceMOUNTAIN... ► Artikel lesen | |
| ECKERT & ZIEGLER | 15,110 | -2,01 % | EQS-AFR: Eckert & Ziegler SE: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114, 115, 117 WpHG | EQS Vorabbekanntmachung Finanzberichte: Eckert & Ziegler SE
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Eckert & Ziegler SE: Vorabbekanntmachung... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 24,020 | +1,22 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 7,430 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance | ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 7,150 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Fourth Quarter and Full Year 2025 Results | SCOTTSDALE, Ariz., Feb. 25, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen |
Das Unternehmen ZOMEDICA CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,095 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZOMEDICA CORP finden Sie auf Wallstreet Online.